StockData
Medtronic plc logo

Medtronic plc (MDT) stock

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/301% above fair value
$100.72−1.60 (-1.56%)

Close on Nov 18, 2026Market cap $128.84BP/E 24.7Yield 2.82%

Medtronic net income

Net income is the profit left for shareholders after every expense, interest and tax.

Medtronic's net income for the twelve months ending Jul 31, 2026 was $5.23B, up 12.3% year over year. For fiscal 2026 it was $4.80B, up 3.0% from the year before. Over ten years it grew 3.1% a year on average. The highest annual figure on record is $5.04B in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2026Apr 24, 2026$4.80B+3.0%
FY2025Apr 25, 2025$4.66B+26.8%
FY2024Apr 26, 2024$3.68B-2.2%
FY2023Apr 28, 2023$3.76B-25.4%
FY2022Apr 29, 2022$5.04B+39.7%
FY2021Apr 30, 2021$3.61B-24.7%
FY2020Apr 24, 2020$4.79B+3.4%
FY2019Apr 26, 2019$4.63B+49.2%
FY2018Apr 27, 2018$3.10B-22.9%
FY2017Apr 28, 2017$4.03B+13.8%
FY2016Apr 29, 2016$3.54B+32.3%
FY2015Apr 24, 2015$2.68B-12.7%
FY2014Apr 25, 2014$3.07B-11.6%
FY2013Apr 26, 2013$3.47B–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$1.47B+41.3%
Q4 FY2026CQ1 2026Apr 24, 2026$1.24B+17.8%
Q3 FY2026CQ4 2025Jan 23, 2026$1.14B-11.7%
Q2 FY2026CQ3 2025Oct 24, 2025$1.37B+8.2%
Q1 FY2026CQ2 2025Jul 25, 2025$1.04B-0.2%
Q4 FY2025CQ1 2025Apr 25, 2025$1.06B+61.5%
Q3 FY2025CQ4 2024Jan 24, 2025$1.29B-2.1%
Q2 FY2025CQ3 2024Oct 25, 2024$1.27B+39.7%
Q1 FY2025CQ2 2024Jul 26, 2024$1.04B+31.7%
Q4 FY2024CQ1 2024Apr 26, 2024$654.00M-44.5%
Q3 FY2024CQ4 2023Jan 26, 2024$1.32B+8.2%
Q2 FY2024CQ3 2023Oct 27, 2023$909.00M+112.9%
Q1 FY2024CQ2 2023Jul 28, 2023$791.00M-14.9%
Q4 FY2023CQ1 2023Apr 28, 2023$1.18B-20.6%
Q3 FY2023CQ4 2022Jan 27, 2023$1.22B-17.4%
Q2 FY2023CQ3 2022Oct 28, 2022$427.00M-67.4%
Q1 FY2023CQ2 2022Jul 29, 2022$929.00M+21.8%
Q4 FY2022CQ1 2022Apr 29, 2022$1.49B+9.2%
Q3 FY2022CQ4 2021Jan 28, 2022$1.48B+16.5%
Q2 FY2022CQ3 2021Oct 29, 2021$1.31B+168.1%
Q1 FY2022CQ2 2021Jul 30, 2021$763.00M+56.7%
Q4 FY2021CQ1 2021Apr 30, 2021$1.36B+110.5%
Q3 FY2021CQ4 2020Jan 29, 2021$1.27B-33.7%
Q2 FY2021CQ3 2020Oct 30, 2020$489.00M-64.1%
Q1 FY2021CQ2 2020Jul 31, 2020$487.00M-43.6%
Q4 FY2020CQ1 2020Apr 24, 2020$646.00M-44.9%
Q3 FY2020CQ4 2019Jan 24, 2020$1.92B+50.9%
Q2 FY2020CQ3 2019Oct 25, 2019$1.36B+22.3%
Q1 FY2020CQ2 2019Jul 26, 2019$864.00M-19.6%
Q4 FY2019CQ1 2019Apr 26, 2019$1.17B-19.7%
Q3 FY2019CQ4 2018Jan 25, 2019$1.27B–
Q2 FY2019CQ3 2018Oct 26, 2018$1.12B-44.7%
Q1 FY2019CQ2 2018Jul 27, 2018$1.08B+5.8%
Q4 FY2018CQ1 2018Apr 27, 2018$1.46B+25.5%
Q3 FY2018CQ4 2017Jan 26, 2018-$1.39B-269.2%
Q2 FY2018CQ3 2017Oct 27, 2017$2.02B+80.9%
Q1 FY2018CQ2 2017Jul 28, 2017$1.02B–
Q4 FY2017CQ1 2017Apr 28, 2017$1.16B–
Q3 FY2017CQ4 2016Jan 27, 2017$821.00M–
Q2 FY2017CQ3 2016Oct 28, 2016$1.12B–

More Medtronic figures

See a number that looks wrong?